Clinical Trial Update: Safety Study of Pharmacokinetics of XL888 in Adults With Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 safety and pharmacokinetics study of XL888 in adults with solid tumors was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• XL888

Snippet

Sponsor: Exelixis | Conditions: Cancer | Phase 1 | Status: TERMINATED